Genomic profile of Toll-like receptor pathways in traumatically brain-injured mice: Effect of exogenous progesterone

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Hua, Fang ^a   Wang, Jun ^a   Ishrat, Tauheed ^a   Wei, Wenjing ^a   Atif, Fahim ^a   Sayeed, Iqbal ^a   Stein, Donald G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Mouse; Toll like receptors progesterone; Traumatic brain injury

Indexed keywords

ADAPTOR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROGESTERONE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CCL2 GENE; CD14 GENE; CEBPB GENE; CLEC4E GENE; CONTROLLED STUDY; CSF3 GENE; CXCL10 GENE; DOWN REGULATION; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HSPA1A GENE; IL 10 GENE; IL1A GENE; IL1B GENE; IL1R1 GENE; IL6 GENE; MALE; MD 1 GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PGRP GENE; PTGS2 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TICAM2 GENE; TLR1 GENE; TLR2 GENE; TLR9 GENE; TNFA GENE; TNFRSF1A GENE; TRAUMATIC BRAIN INJURY; UNINDEXED SEQUENCE; UPREGULATION; ANIMAL; BRAIN; BRAIN INJURY; C57BL MOUSE; DRUG EFFECT; GENETICS; HUMAN; INFLAMMATION; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY;

ANIMALS; BRAIN; BRAIN INJURIES; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PROGESTERONE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 79955664412     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-42     Document Type: Article

References (47)

1. Morganti-Kossmann MC, Satgunaseelan L, Bye N, Kossmann T. Modulation of immune response by head injury. Injury 2007, 38:1392-1400. 10.1016/j.injury.2007.10.005, 18048036.
2. Harting MT, Jimenez F, Adams SD, Mercer DW, Cox CS. Acute, regional inflammatory response after traumatic brain injury: Implications for cellular therapy. Surgery 2008, 144:803-813. 10.1016/j.surg.2008.05.017, 19081024.
3. Homsi S, Federico F, Croci N, Palmier B, Plotkine M, Marchand-Leroux C, Jafarian-Tehrani M. Minocycline effects on cerebral edema: relations with inflammatory and oxidative stress markers following traumatic brain injury in mice. Brain Res 2009, 1291:122-132.
4. Israelsson C, Wang Y, Kylberg A, Pick CG, Hoffer BJ, Ebendal T. Closed head injury in a mouse model results in molecular changes indicating inflammatory responses. J Neurotrauma 2009, 26:1307-1314. 10.1089/neu.2008.0676, 2989856, 19317611.
5. Cederberg D, Siesjö P. What has inflammation to do with traumatic brain injury?. Childs Nerv Syst 2010, 26:221-226. 10.1007/s00381-009-1029-x, 19940996.
6. Ziebell JM, Morganti-Kossmann MC. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 2010, 7:22-30. 10.1016/j.nurt.2009.10.016, 20129494.
7. Sayeed I, Stein DG. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog Brain Res 2009, 175:219-237.
8. Stein DG. Progesterone exerts neuroprotective effects after brain injury. Brain Res Rev 2008, 57:386-397. 10.1016/j.brainresrev.2007.06.012, 2699575, 17826842.
9. Stein DG, Sayeed I. Is progesterone worth consideration as a treatment for brain injury?. AJR Am J Roentgenol 2010, 194:20-22. 10.2214/AJR.09.3407, 20028900.
10. Stein DG, Wright DW. Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin Investig Drugs 2010, 19:847-857. 10.1517/13543784.2010.489549, 20486864.
11. Cekic M, Stein DG. Traumatic brain injury and aging: is a combination of progesterone and vitamin D hormone a simple solution to a complex problem?. Neurotherapeutics 2010, 7:81-90. 10.1016/j.nurt.2009.10.017, 2834197, 20129500.
12. Shear DA, Galani R, Hoffman SW, Stein DG. Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury. Exp Neurol 2002, 178:59-67. 10.1006/exnr.2002.8020, 12460608.
13. He J, Evans CO, Hoffman SW, Oyesiku NM, Stein DG. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol 2004, 189:404-412. 10.1016/j.expneurol.2004.06.008, 15380490.
14. Pettus EH, Wright DW, Stein DG, Hoffman SW. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res 2005, 1049:112-119. 10.1016/j.brainres.2005.05.004, 15932748.
15. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406:782-787. 10.1038/35021228, 10963608.
16. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2:675-680. 10.1038/90609, 11477402.
17. Casanova JL, Abel L, Quintana-Murci L. Human TLRs and IL-1Rs in Host Defense: Natural Insights from Evolutionary, Epidemiological, and Clinical Genetics. Annu Rev Immunol 2011, 23:447-491.
18. O'Neill LA. How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 2006, 18:3-9. 10.1016/j.coi.2005.11.012, 16343886.
19. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005, 17:1-14.
20. Crack PJ, Bray PJ. Toll-like receptors in the brain and their potential roles in neuropathology. Immunol Cell Biol 2007, 85:476-480. 10.1038/sj.icb.7100103, 17667932.
21. Mishra BB, Mishra PK, Teale JM. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. J Neuroimmunol 2006, 181:46-56. 10.1016/j.jneuroim.2006.07.019, 1779953, 17011049.
22. Brightbill HD, Modlin RL. Toll-like receptors: molecular mechanisms of the mammalian immune response. Immunology 2000, 101:1-10. 10.1046/j.1365-2567.2000.00093.x, 2327044, 11012747.
23. Naert G, Laflamme N, Rivest S. Toll-like receptor 2-independent and MyD88-dependent gene expression in the mouse brain. J Innate Immun 2009, 1:480-493. 10.1159/000225990, 20375605.
24. Shimada M, Yanai Y, Okazaki T, Noma N, Kawashima I, Mori T, Richards JS. Hyaluronan fragments generated by sperm-secreted hyaluronidase stimulate cytokine/chemokine production via the TLR2 and TLR4 pathway in cumulus cells of ovulated COCs, which may enhance fertilization. Development 2008, 135:2001-2011. 10.1242/dev.020461, 18434414.
25. Marsh BJ, Williams-Karnesky RL, Stenzel-Poore MP. Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 2009, 158:1007-1020. 10.1016/j.neuroscience.2008.07.067, 2674023, 18809468.
26. Jenkins KA, Mansell A. TIR-containing adaptors in Toll-like receptor signalling. Cytokine 2010, 49:237-244. 10.1016/j.cyto.2009.01.009, 19264502.
27. Prat A, Antel J. Pathogenesis of multiple sclerosis. Curr Opin Neurol 2005, 18:225-230. 10.1097/01.wco.0000169737.99040.31, 15891404.
28. Letiembre M, Liu Y, Walter S, Hao W, Pfander T, Wrede A, Schulz-Schaeffer W, Fassbender K. Screening of innate immune receptors in neurodegenerative diseases: A similar pattern. Neurobiol Aging 2007, 30:759-768.
29. Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology 2008, 55:310-318. 10.1016/j.neuropharm.2008.01.005, 2603601, 18308346.
30. Gao Y, Fang X, Tong Y, Liu Y, Zhang B. TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice. Biomed Pharmacother 2009, 63:442-450. 10.1016/j.biopha.2008.06.028, 18804339.
31. Hua F, Ma J, Ha T, Kelley J, Kao RL, Schweitzer JB, Kalbfleisch JH, Williams DL, Li C. Differential Roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice. Brain Research 2009, 1262:100-108. 2722683, 19401158.
32. Hua F, Ma J, Ha T, Xia Y, Kelley J, Williams DL, Kao RL, Browder IW, Schweitzer JB, Kalbfleisch JH, Li C. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J Neuroimmunol 2007, 190:101-111. 10.1016/j.jneuroim.2007.08.014, 2453597, 17884182.
33. Kigerl KA, Lai W, Riverst S, Hart RP, Satoskar AR, Popovich PG. Progesterone Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem 2007, 102:37-50. 10.1111/j.1471-4159.2007.04524.x, 17403033.
34. Harburger LL, Saadi A, Frick KM. Dose-dependent effects of post-training estradiol plus progesterone treatment on object memory consolidation and hippocampal extracellular signal-regulated kinase activation in young ovariectomized mice. Neuroscience 2009, 160:6-12. 10.1016/j.neuroscience.2009.02.024, 2668744, 19223011.
35. Wright DW, Hoffman SW, Virmani S, Stein DG. Effects of medroxyprogesterone acetate on cerebral oedema and spatial learning performance after traumatic brain injury in rats. Brain Inj 2008, 22:107-113. 10.1080/02699050701867399, 18240039.
36. Pan DS, Liu WG, Yang XF, Cao F. Inhibitory effect of progesterone on inflammatory factors after experimental traumatic brain injury. Biomed Environ Sci 2007, 20:432-438.
37. Chase MA, Wheeler DS, Lierl KM, Hughes VS, Wong HR, Page K. Hsp72 induces inflammation and regulates cytokine production in airway epithelium through a TLR4- and NF-kappaB-dependent mechanism. J Immunol 2007, 179:6318-6324. 2755189, 17947709.
38. Kimoto M, Nagasawa K, Miyake K. Role of TLR4/MD-2 and RP105/MD-1 in innate recognition of lipopolysaccharide. Scand J Infect Dis 2003, 35:568-572. 10.1080/00365540310015700, 14620136.
39. Wang JY, Lin CG, Hsiao YH, Liou YH, Wu LS. Single nucleotide polymorphisms and haplotype of MD-1 gene associated with high serum IgE phenotype with mite-sensitive allergy in Taiwanese children. Int J Immunogenet 2007, 34:407-412. 10.1111/j.1744-313X.2007.00711.x, 18001295.
40. Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J Biol Chem 2003, 278:49751-49762. 10.1074/jbc.M305820200, 14519765.
41. Brinton RD, Thompson RF, Foy MR, Baudry M, Wang J, Finch CE, Morgan TE, Pike CJ, Mack WJ, Stanczyk FZ, Nilsen J. Progesterone receptors: form and function in brain. Front Neuroendocrinol 2008, 29:313-339. 10.1016/j.yfrne.2008.02.001, 2398769, 18374402.
42. Allan GF, Tsai SY, Tsai MJ, O'Malley BW. Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding. Proc Natl Acad Sci 1992, 89:11750-11754. 10.1073/pnas.89.24.11750, 50634, 1465392.
43. Leonhardt SA, Boonyaratanakornkit V, Edwards DP. Progesterone receptor transcription and non-transcription signaling mechanisms. Steroids 2003, 68:761-770. 10.1016/S0039-128X(03)00129-6, 14667966.
44. Rohe HJ, Ahmed IS, Twist KE, Craven RJ. PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding. Pharmacol Ther 2009, 121:14-19. 10.1016/j.pharmthera.2008.09.006, 2659782, 18992768.
45. Stevens SL, Ciesielski TM, Marsh BJ, Yang T, Homen DS, Boule JL, Lessov NS, Simon RP, Stenzel-Poore MP. Toll-like receptor 9: a new target of ischemic preconditioning in the brain. J Cereb Blood Flow Metab 2008, 28:1040-1047. 10.1038/sj.jcbfm.9600606, 3037270, 18183029.
46. Chen G, Shi JX, Qi M, Wang HX, Hang CH. Effects of progesterone on intestinal inflammatory response, mucosa structure alterations, and apoptosis following traumatic brain injury in male rats. J Surg Res 2008, 147:92-98. 10.1016/j.jss.2007.05.029, 17868700.
47. Feng D, Xu W, Chen G, Hang C, Gao H, Yin H. Influence of glutamine on intestinal inflammatory response, mucosa structure alterations and apoptosis following traumatic brain injury in rats. J Int Med Res 2007, 35:644-656.